Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Consolidated Net Income: 2023-2024

Historic Consolidated Net Income for Artiva Biotherapeutics (ARTV) over the last 2 years, with Dec 2024 value amounting to -$16.1 million.

  • Artiva Biotherapeutics' Consolidated Net Income fell 41.30% to -$16.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$61.9 million, marking a year-over-year change of. This contributed to the annual value of -$65.4 million for FY2024, which is 127.62% down from last year.
  • Latest data reveals that Artiva Biotherapeutics reported Consolidated Net Income of -$16.1 million as of Q4 2024, which was up 2.42% from -$16.5 million recorded in Q3 2024.
  • In the past 5 years, Artiva Biotherapeutics' Consolidated Net Income registered a high of $11.2 million during Q3 2023, and its lowest value of -$16.7 million during Q2 2023.
  • Over the past 2 years, Artiva Biotherapeutics' median Consolidated Net Income value was -$15.5 million (recorded in 2024), while the average stood at -$11.3 million.
  • Examining YoY changes over the last 5 years, Artiva Biotherapeutics' Consolidated Net Income showed a top increase of 6.90% in 2024 and a maximum decrease of 246.84% in 2024.
  • Artiva Biotherapeutics' Consolidated Net Income (Quarterly) stood at -$11.4 million in 2023, then plummeted by 41.30% to -$16.1 million in 2024.
  • Its last three reported values are -$16.1 million in Q4 2024, -$16.5 million for Q3 2024, and -$15.5 million during Q2 2024.